Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-26 @ 1:42 AM
NCT ID:
NCT02041533
Group ID:
EG002
Title:
Post Chemotherapy Optional Nivolumab
Description:
Participants from the Investigator Choice Arm who progressed during Post-Chemotherapy Phase could receive crossover nivolumab treatment after disease progression. These participants received Nivolumab 3 mg/kg IV infusion every 2 weeks until disease progression, discontinuation due to unacceptable toxicity, withdrawal of consent or study closure.
Deaths Number Affected:
136
Deaths Number At Risk:
None
Serious Number Affected:
110
Serious Number At Risk:
159
Other Number Affected:
137
Other Number At Risk:
159
Study:
NCT02041533
Results Section:
NCT02041533
Adverse Events Module:
NCT02041533